CLINICAL_TRIALS
trial_result
· 2008-12-18
Clinical Trial Update: SA4503 8-Week Study in Major Depressive Disorder (MDD) [Phase 2]
Summary
A Phase 2 trial of SA4503 for major depressive disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M's Science Corporation | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED